ArticleBMJ (Clinical research ed.)2005

Risk of gastrointestinal effects with COX-2 inhibitors and NSAIDs: what does evidence from randomised trials show about celecoxib?

Jonathan L UnderhillPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.